Priming with Toll-like receptor 3 agonist or interferon-gamma enhances the therapeutic effects of human mesenchymal stem cells in a murine model of atopic dermatitis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Priming with Toll-like receptor 3 agonist or interferon-gamma enhances the therapeutic effects of human mesenchymal stem cells in a murine model of atopic dermatitis
Authors
Keywords
Mesenchymal stem cells, Priming, Atopic dermatitis, Toll-like receptor 3 agonist, Interferon-γ
Journal
Stem Cell Research & Therapy
Volume 10, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-02-22
DOI
10.1186/s13287-019-1164-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mesenchymal Stem Cell Therapy for Inflammatory Skin Diseases: Clinical Potential and Mode of Action
- (2017) Tae-Hoon Shin et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Clinical Trial of Human Umbilical Cord Blood-Derived Stem Cells for the Treatment of Moderate-to-Severe Atopic Dermatitis: Phase I/IIa Studies
- (2016) Hyung-Sik Kim et al. STEM CELLS
- Conditioned Medium from Hypoxic Bone Marrow-Derived Mesenchymal Stem Cells Enhances Wound Healing in Mice
- (2014) Lei Chen et al. PLoS One
- Causal analysis approaches in Ingenuity Pathway Analysis
- (2013) Andreas Krämer et al. BIOINFORMATICS
- Human Umbilical Cord Blood Mesenchymal Stem Cells Reduce Colitis in Mice by Activating NOD2 Signaling to COX2
- (2013) Hyung–Sik Kim et al. GASTROENTEROLOGY
- Infant origins of childhood asthma associated with specific molds
- (2012) Tiina Reponen et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Human Mesenchymal Stem/Stromal Cells Cultured as Spheroids are Self-activated to Produce Prostaglandin E2 that Directs Stimulated Macrophages into an Anti-inflammatory Phenotype
- (2012) Joni H. YlÖstalo et al. STEM CELLS
- Toll-Like Receptors as Modulators of Mesenchymal Stem Cells
- (2012) Olga DelaRosa et al. Frontiers in Immunology
- Atopic dermatitis: a disease of altered skin barrier and immune dysregulation
- (2011) Mark Boguniewicz et al. IMMUNOLOGICAL REVIEWS
- Tolerance-like mediated suppression by mesenchymal stem cells in patients with dust mite allergy–induced asthma
- (2011) Simi Kapoor et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Human Gingiva-Derived Mesenchymal Stromal Cells Attenuate Contact Hypersensitivity via Prostaglandin E2-Dependent Mechanisms
- (2011) Wen-Ru Su et al. STEM CELLS
- The immunomodulatory properties of mesenchymal stem cells and their use for immunotherapy
- (2010) Martin J Hoogduijn et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- A New Mesenchymal Stem Cell (MSC) Paradigm: Polarization into a Pro-Inflammatory MSC1 or an Immunosuppressive MSC2 Phenotype
- (2010) Ruth S. Waterman et al. PLoS One
- Bone marrow stromal cells use TGF- to suppress allergic responses in a mouse model of ragweed-induced asthma
- (2010) K. Nemeth et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The role of dendritic cells and regulatory T cells in the regulation of allergic asthma
- (2009) Jennifer T. Burchell et al. PHARMACOLOGY & THERAPEUTICS
- A critical role of IFNγ in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7-H1
- (2008) Huiming Sheng et al. CELL RESEARCH
- IFN-γ activation of mesenchymal stem cells for treatment and prevention of graft versus host disease
- (2008) David Polchert et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- A Role for Th17 Cells in the Immunopathogenesis of Atopic Dermatitis?
- (2008) Antonella Di Cesare et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Possible Pathogenic Role of Th17 Cells for Atopic Dermatitis
- (2008) Chizuko Koga et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Atopic Dermatitis
- (2008) Thomas Bieber NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started